18th Dec 2007 17:36
GlaxoSmithKline PLC18 December 2007 GlaxoSmithKline plc received on 17 December 2007 from Legal & General Group plc a notification of interests inGlaxoSmithKline plc Ordinary shares of 25 pence each, dated 17 December 2007. This notice is given in accordance withDTR 5.8.12. TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing GlaxoSmithKline Plcshares to which voting rights are attached:2. Reason for notification (yes/no)An acquisition or disposal of voting rights YesAn acquisition or disposal of financial instruments which may result in the acquisitionof shares already issued to which voting rights are attachedAn event changing the breakdown of voting rightsOther (please specify):______________3. Full name of person(s) subject to the notification Legal & General Group Plc (Group)obligation: Legal & General Investment Management Limited (LGIM)4. Full name of shareholder(s) (if different from 3.): Legal & General Assurance (Pensions Management) Limited (PMC) Legal & General Group Plc (L&G)5. Date of the transaction (and date on which the threshold is 12 December 2007crossed or reached if different):6. Date on which issuer notified: 17 December 20077. Threshold(s) that is/are crossed or reached: Above 5% (Group) Above 5% (LGIM) 8. Notified details: A: Voting rights attached to sharesClass/type of Situation previous to Resulting situation after the triggering transactionshares the Triggering transaction if possible Number of Number of Number of Number of voting rights % of voting rightsusing the Shares Voting sharesISIN CODE Rights Direct Direct Indirect Direct IndirectORD Below 5% 262,702,444 262,702,444 21,129,709 4.769 0.383 GBP0.25 B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument Period/ Date that may be acquired if rights the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 283,832,153 5.15 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable:Legal & General Group Plc (Direct and Indirect) (Group) (283,832,153 -5.15% = Total Position)Legal & General Investment Management (Holdings) Limited (LGIMH) (Directand Indirect) (283,832,153 - 5.15% = Total Position)Legal & General Investment Management Limited (Indirect) (LGIM)(283,832,153 - 5.15% = Total Position) Legal & General Group Plc (Direct) (L&G) (262,702,444 - 4.76 % = LGAS, LGPL & PMC)Legal & General Investment Management (Holdings) Limited Legal & General Insurance Holdings Limited (Direct)(Direct) (LGIMHD) (213,985,881 -3.88 % = PMC) (LGIH)Legal & General Assurance (Pensions Management) Limited (PMC) Legal & General Assurance Society Limited (LGAS & LGPL)(213,985,881 -3.88 % = PMC) Legal & General Pensions Limited (Direct) (LGPL) Proxy Voting:10. Name of the proxy holder: N/A11. Number of voting rights proxy holder will cease to hold: N/A12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: Notification using the total voting rights figure of 5,507,831,537 Please note this notification has been delayed due to the large number of disclosures required following a substantial amount of new business which has come to us in the form of an in-specie transfer.14. Contact name: Helen Lewis (LGIM)15. Contact telephone number: 020 3124 3851 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
GlaxosmithklineLegal & General